Home Data Calendar Blog

LCI

Tables

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Common Stock Value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 NA 0.01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.01 0.01 NA NA NA NA NA NA NA

Weighted Average Number Of Diluted Shares Outstanding 10.29 10.24 NA 10.13 10.09 9.98 NA 9.88 9.86 9.77 NA 9.68 10.14 9.58 NA 9.83 9.78 9.40 NA 9.57 9.57 9.43 NA 9.44 9.42 9.17 NA 9.12 9.35 9.35 NA 9.30 9.27 9.24 NA 9.19 9.07 7.40 NA 7.28 7.11 7.12 NA 7.18 7.19 7.17 NA 7.09 6.44 6.22 NA NA NA NA

Weighted Average Number Of Shares Outstanding Basic 10.29 10.24 NA 10.13 10.09 9.98 NA 9.88 9.86 9.77 NA 9.68 9.65 9.58 NA 9.46 9.44 9.40 NA 9.28 9.27 9.25 NA 9.21 9.20 9.17 NA 9.12 9.10 9.08 NA 8.97 8.92 8.90 NA 8.76 8.67 7.40 NA 7.12 7.09 7.07 NA 7.14 7.13 7.11 NA 7.09 6.36 6.22 NA NA NA NA

Earnings Per Share Basic -3.52 -2.72 -9.20 -3.44 -8.04 -2.24 -18.04 -0.72 -17.44 -0.68 -1.00 -1.72 0.52 -1.28 -0.80 1.12 1.32 -30.60 -1.20 1.36 1.52 1.44 0.64 1.64 0.88 -3.20 0.40 -0.60 1.48 3.64 3.76 4.04 5.04 3.92 2.64 2.64 1.92 -0.80 0.48 0.56 0.40 0.40 0.20 0.24 0.08 0.04 -0.28 -0.04 0.36 -0.08 0.44 0.32 0.00 0.48

Earnings Per Share Diluted -3.52 -2.72 -9.20 -3.44 -8.04 -2.24 -18.04 -0.72 -17.44 -0.68 -1.00 -1.72 0.52 -1.28 -0.80 1.08 1.28 -30.60 -1.20 1.32 1.48 1.40 0.60 1.60 0.88 -3.20 0.40 -0.60 1.44 3.56 3.64 3.88 4.84 3.76 2.56 2.52 1.84 -0.80 0.48 0.56 0.40 0.40 0.20 0.24 0.08 0.04 -0.28 -0.04 0.36 -0.08 0.44 0.32 0.00 0.44

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Revenue From Contract With Customer Excluding Assessed Tax 80.89 75.08 74.19 78.36 86.51 101.53 106.01 112.37 133.92 126.48 137.92 144.37 136.11 127.34 133.84 172.79 193.72 155.05 170.91 174.39 184.31 154.96 139.12 161.72 170.94 161.56 168.89 140.11 127.06 106.43 99.28 99.35 114.82 93.39 80.62 80.00 67.33 45.83 40.17 39.02 36.56 35.29 35.69 30.69 27.73 28.88 25.51 25.89 30.04 25.40 33.76 31.27 28.72 31.43

Revenue From Contract With Customer Including Assessed Tax 80.89 75.08 74.19 78.36 86.51 101.53 106.01 112.37 133.92 126.48 137.92 144.37 136.11 127.34 133.84 172.79 193.72 155.05 170.91 174.39 184.31 154.96 139.12 165.72 170.94 161.56 168.89 140.11 127.06 106.43 99.28 99.35 114.82 93.39 80.62 80.00 67.33 45.83 40.17 39.02 36.56 35.29 35.69 30.69 27.73 28.88 25.51 25.89 30.04 25.40 33.76 31.27 28.72 31.43

Revenues 80.89 75.08 74.19 78.36 86.51 101.53 106.01 112.37 133.92 126.48 137.92 144.37 136.11 127.34 133.84 172.79 193.72 155.05 170.91 174.39 184.31 154.96 139.12 161.72 170.94 161.56 168.89 140.11 127.06 106.43 99.28 99.35 114.82 93.39 80.62 80.00 67.33 45.83 40.17 39.02 36.56 35.29 35.69 30.69 27.73 28.88 25.51 25.89 30.04 25.40 33.76 31.27 28.72 31.43

Cost Of Goods And Service Excluding Depreciation Depletion And Amortization 65.26 61.28 63.83 72.66 76.99 81.01 79.60 82.06 124.49 92.19 89.81 94.38 86.66 77.66 76.59 99.57 115.75 87.69 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Gross Profit 14.28 12.60 7.86 3.08 5.71 16.52 22.66 26.46 0.78 25.70 39.59 41.68 41.29 42.66 49.34 65.32 69.81 59.14 66.53 67.06 87.45 67.67 58.88 72.43 88.05 81.85 79.93 57.49 71.64 77.43 71.95 75.64 87.20 71.57 55.93 56.13 41.04 1.31 15.20 15.17 13.42 13.63 12.01 10.89 7.43 8.62 3.75 5.30 8.36 5.90 11.33 10.40 8.08 11.53

Operating Expenses 29.05 25.63 85.82 25.16 73.79 24.67 46.14 23.61 217.37 25.72 44.12 43.77 24.52 33.25 39.94 31.94 33.13 400.92 57.93 33.78 40.31 26.99 30.07 28.79 53.75 102.16 49.53 38.87 41.32 26.01 20.93 21.36 20.66 16.92 18.58 20.14 15.68 11.92 9.53 10.47 8.73 9.94 9.41 8.53 6.93 7.17 7.19 6.13 4.54 6.64 7.31 7.75 6.78 6.79

Research And Development Expense 4.93 7.18 6.04 5.81 4.75 5.76 6.02 5.97 5.64 6.54 6.69 7.44 6.91 8.94 9.44 9.84 9.72 9.81 8.34 2.73 10.72 7.41 11.42 8.34 9.94 12.37 12.96 16.50 9.07 6.53 6.98 9.16 7.84 6.36 6.60 10.58 5.79 4.75 3.69 5.23 3.57 3.76 3.99 2.91 2.51 2.43 3.03 1.85 1.66 2.04 NA NA NA NA

Selling General And Administrative Expense 18.32 16.70 25.75 17.57 18.79 18.91 21.58 17.64 13.73 15.14 18.59 22.15 17.42 21.31 22.21 21.65 23.20 20.59 20.55 14.11 28.49 19.04 16.52 17.63 18.07 21.26 21.97 16.16 14.67 15.54 13.95 12.20 12.82 10.55 11.98 9.56 9.89 7.18 5.84 5.25 5.16 6.17 5.41 5.62 4.42 4.74 4.16 4.28 2.87 4.60 NA NA NA NA

Operating Income Loss -14.77 -13.03 -77.96 -22.08 -68.08 -8.15 -23.48 2.85 -216.60 -0.01 -4.53 -2.09 16.77 9.40 9.40 33.38 36.68 -341.78 8.60 33.28 47.13 40.68 28.81 43.64 34.31 -20.31 30.39 18.62 30.32 51.42 51.02 54.27 66.54 54.65 37.35 35.99 25.37 -10.62 5.68 4.70 4.69 3.69 2.61 2.36 0.49 1.45 -3.43 -0.83 3.82 -0.74 4.02 2.65 1.30 4.74

Interest Expense 15.18 15.03 14.81 14.52 14.43 14.22 13.22 12.63 13.50 14.49 14.68 16.18 16.69 19.29 20.19 21.48 21.51 21.43 21.19 22.84 20.69 20.91 20.72 22.37 23.33 22.99 27.12 26.99 11.77 0.06 0.09 0.01 0.07 0.04 0.01 0.01 0.05 0.06 0.06 0.06 0.07 0.06 0.06 0.06 0.07 0.08 0.04 0.03 0.08 0.07 NA NA NA NA

Interest Paid Net 18.36 2.82 13.56 2.02 15.03 0.10 4.19 8.83 11.60 10.24 12.37 11.79 12.45 15.32 16.02 16.54 17.47 16.72 16.82 15.49 15.54 15.71 15.69 16.44 17.61 17.37 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Allocated Share Based Compensation Expense 1.53 1.58 1.38 1.70 2.31 3.02 1.84 1.86 1.99 3.34 1.88 1.87 2.01 4.46 2.05 1.99 1.95 3.04 2.88 2.27 2.56 2.19 1.76 1.79 1.72 2.46 3.14 2.02 2.02 4.37 1.67 1.51 1.57 1.65 3.19 2.79 2.15 0.90 0.28 0.25 0.28 0.66 NA NA NA NA NA NA NA NA NA NA NA NA

Income Tax Expense Benefit 0.03 0.03 0.49 -1.36 -1.37 -0.06 129.22 -2.54 -58.08 -7.98 -10.08 -1.70 -5.30 1.79 -2.54 1.36 2.65 -75.60 -0.88 -2.27 18.14 7.42 3.10 7.34 3.54 -12.88 -2.95 -2.74 5.96 17.05 17.22 17.97 22.43 19.80 14.02 13.28 9.80 -4.24 1.95 1.33 1.75 2.28 0.81 1.06 0.52 0.21 -1.01 -0.45 1.39 -0.39 1.29 0.53 1.17 1.83

Income Taxes Paid Net NA NA 0.02 -0.00 0.00 -0.59 -13.78 -21.58 -1.17 -0.30 0.01 0.10 2.60 5.07 1.77 5.58 0.29 -12.28 0.20 0.81 -7.80 0.23 0.03 5.56 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Profit Loss -36.31 -28.02 -93.30 -34.90 -81.08 -22.34 -177.89 -7.14 -171.95 -6.50 -9.70 -16.59 5.08 -12.16 -7.59 10.64 12.36 -287.53 -11.36 12.77 14.02 13.26 5.73 14.93 8.19 -29.39 3.59 -5.47 13.54 33.20 33.96 36.26 44.82 34.95 23.55 23.01 16.59 -5.99 3.62 3.96 2.86 2.94 1.43 1.73 0.63 0.22 -1.85 -0.36 2.36 -0.39 NA NA NA NA

Other Comprehensive Income Loss Net Of Tax 0.03 0.01 0.12 -0.01 0.01 0.02 0.06 -0.01 -0.05 0.08 0.01 -0.06 0.08 -0.05 -0.04 -0.07 0.01 0.01 -0.07 -0.10 -0.13 0.00 -0.04 0.08 0.04 -0.00 NA -0.01 0.04 -0.02 -0.01 0.04 -0.27 NA -0.01 -0.01 0.01 -0.00 0.03 -0.05 -0.00 0.04 -0.04 -0.01 NA NA NA NA NA NA NA NA NA NA

Net Income Loss -36.31 -28.02 -93.30 -34.90 -81.08 -22.34 -177.89 -7.14 -171.95 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Comprehensive Income Net Of Tax -36.27 -28.01 -93.18 -34.91 -81.08 -22.32 -177.83 -7.15 -172.00 NA NA NA NA NA NA NA NA NA -11.42 12.67 13.90 13.26 5.68 15.01 8.21 -29.41 3.56 -5.50 13.56 33.16 33.93 36.27 44.55 34.93 23.53 22.98 16.58 -6.00 3.60 3.89 2.88 2.97 1.37 1.71 0.58 0.20 NA NA NA NA NA NA NA NA

Net Income Loss Available To Common Stockholders Diluted -36.31 -28.02 -93.30 -34.90 -81.08 -22.34 -177.89 -7.14 -171.95 -6.50 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Assets 438.36 467.30 484.44 572.31 594.94 690.87 683.74 862.37 900.27 1131.92 1136.56 1159.15 1181.08 1171.93 1187.41 1231.61 1319.46 1257.65 1575.30 1597.49 1659.39 1615.79 1603.31 1627.00 1752.92 1734.06 1764.02 1752.38 1752.74 543.00 508.77 463.08 423.73 374.02 342.77 307.32 271.65 175.12 167.75 170.23 168.38 158.82 158.22 151.48 148.10 148.02 147.74 NA NA NA NA NA NA NA

Liabilities 750.63 744.86 735.50 731.62 721.10 738.22 711.21 738.32 771.01 832.61 833.66 848.61 855.91 853.83 853.37 892.31 992.95 945.63 976.39 990.52 1066.60 1039.52 1042.19 1073.08 1216.27 1206.33 1209.56 1204.85 1203.08 41.12 45.00 35.83 44.11 41.39 48.01 38.28 35.57 30.01 38.94 46.44 50.29 43.91 46.91 41.90 40.80 41.72 42.06 NA NA NA NA NA NA NA

Liabilities And Stockholders Equity 438.36 467.30 484.44 572.31 594.94 690.87 683.74 862.37 900.27 1131.92 1136.56 1159.15 1181.08 1171.93 1187.41 1231.61 1319.46 1257.65 1575.30 1597.49 1659.39 1615.79 1603.31 1627.00 1752.92 1734.06 1764.02 1752.38 1752.74 543.00 508.77 463.08 423.73 374.02 342.77 307.32 271.65 175.12 167.75 170.23 168.38 158.82 158.22 151.48 148.10 148.02 147.74 NA NA NA NA NA NA NA

Stockholders Equity -312.27 -277.56 -251.06 -159.31 -126.16 -47.35 -27.47 124.05 129.26 299.31 302.90 NA NA NA 334.04 NA NA NA 598.91 NA NA NA 561.12 553.92 536.65 527.29 554.05 547.14 549.27 501.52 463.41 426.91 379.30 332.32 294.47 268.76 235.82 144.87 128.58 123.61 117.92 114.71 111.12 NA NA NA 105.55 NA NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Assets Current 250.53 264.66 290.12 318.70 334.61 364.89 353.56 369.91 407.80 442.22 443.21 443.31 449.18 435.07 472.25 515.35 594.65 524.39 526.87 521.77 568.25 507.97 523.70 554.72 665.61 645.95 612.82 601.60 607.04 400.42 370.55 367.23 334.03 287.79 265.55 237.09 204.38 122.41 116.13 118.95 116.66 108.03 106.48 99.58 96.06 95.55 94.14 NA NA NA NA NA NA NA

Cash And Cash Equivalents At Carrying Value 55.85 77.92 87.85 106.11 98.64 105.32 93.29 81.29 34.22 108.77 144.33 101.45 119.18 101.01 140.25 205.21 163.77 150.33 98.59 114.02 139.86 92.46 117.74 132.03 247.25 241.68 224.77 225.45 178.83 207.77 200.34 208.77 170.61 137.40 105.59 84.11 94.39 35.73 42.69 33.07 31.45 26.36 22.56 18.99 19.95 17.52 5.28 14.45 23.22 17.62 21.90 NA NA NA

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 60.85 82.92 92.85 111.11 103.64 110.32 98.29 86.29 39.22 108.77 144.33 101.45 119.18 NA 140.25 NA NA NA 98.59 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Accounts Receivable Net Current 80.34 54.92 56.24 63.97 66.28 94.31 98.83 114.69 160.13 138.80 125.69 180.36 158.50 173.11 164.75 151.80 275.36 205.35 252.65 238.77 256.73 243.33 204.07 215.24 222.99 190.53 211.72 183.62 235.01 107.22 91.10 79.72 90.64 75.83 61.33 59.24 51.41 29.75 26.41 39.81 41.37 42.06 42.22 37.50 36.72 34.64 33.46 NA NA NA NA NA NA NA

Inventory Net 94.78 94.12 95.16 95.43 105.78 112.64 109.55 113.07 122.20 156.48 142.87 135.96 152.09 149.16 143.97 136.35 136.13 145.91 141.63 133.29 135.59 125.39 122.60 123.82 130.24 127.75 114.90 116.51 124.01 45.23 46.19 42.47 42.64 44.07 44.84 41.37 35.76 34.52 32.53 32.85 30.69 27.61 27.06 27.98 23.87 26.47 26.90 NA NA NA NA NA NA NA

Other Assets Current 18.26 16.89 14.07 15.95 15.35 15.50 14.17 18.14 23.99 15.79 13.23 14.45 8.71 6.99 13.61 7.25 7.96 7.86 4.86 10.04 6.47 9.32 6.59 7.27 7.89 7.68 6.43 24.00 18.49 4.51 3.17 3.16 4.16 3.34 1.83 2.17 2.34 2.82 1.16 1.85 1.31 2.08 1.02 1.47 1.82 1.60 0.94 NA NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 135.88 135.31 136.43 134.08 129.53 128.80 123.29 119.95 114.36 108.72 102.98 99.75 94.00 89.18 83.42 83.24 79.99 76.90 90.00 85.56 82.02 76.81 71.46 69.41 64.05 58.78 53.60 48.16 44.06 42.16 40.44 39.04 37.68 36.40 35.50 34.31 33.16 32.09 31.00 30.91 30.40 29.43 28.43 27.37 26.44 25.53 24.59 NA NA NA NA NA NA NA

Amortization Of Intangible Assets 1.40 1.20 2.50 2.60 3.80 4.00 3.80 3.90 8.70 8.60 8.50 8.30 8.20 7.00 7.90 7.90 8.20 8.20 8.10 8.30 8.20 8.10 8.10 8.10 8.10 9.30 7.90 7.60 3.80 0.19 0.08 0.02 0.02 0.02 0.00 0.47 0.47 -0.47 -3.31 0.47 0.47 0.47 0.47 0.47 0.47 0.47 0.49 0.46 0.47 0.45 NA NA NA NA

Property Plant And Equipment Net 116.47 124.96 133.18 140.12 143.10 164.15 166.67 168.84 173.16 176.98 179.52 181.41 183.63 184.89 186.67 193.12 195.61 195.88 233.25 267.40 258.21 249.28 243.15 232.32 227.05 221.34 216.64 220.20 198.40 98.62 94.56 80.27 75.28 69.74 61.70 57.01 53.30 40.95 40.14 39.29 38.88 36.81 34.91 30.81 30.04 30.67 29.93 NA NA NA NA NA NA NA

Indefinite Lived Intangible Assets Excluding Goodwill NA NA NA 4.00 4.00 4.00 4.00 4.00 4.00 9.00 9.00 68.00 68.00 68.00 36.45 36.45 36.45 36.45 36.45 36.45 36.45 36.45 36.45 36.45 36.45 59.45 135.45 147.45 250.45 18.45 18.45 NA NA NA 0.15 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Intangible Assets Net Excluding Goodwill 29.64 30.00 32.18 88.35 90.97 135.34 137.84 160.14 163.49 369.15 374.74 401.04 422.85 427.25 411.23 401.97 409.87 416.02 424.43 420.58 439.64 447.80 453.86 461.96 470.06 501.17 575.50 598.42 689.06 28.90 29.09 1.17 1.19 1.21 0.93 0.95 1.41 1.88 2.55 3.02 3.49 3.96 4.43 4.90 5.37 5.84 5.91 NA NA NA 7.79 NA NA NA

Finite Lived Intangible Assets Net 29.64 30.00 32.18 84.35 86.97 131.34 133.84 156.14 159.49 360.15 365.74 333.04 354.85 359.25 374.78 365.52 373.42 379.57 387.98 384.13 403.19 411.35 417.41 425.51 433.62 441.72 440.05 450.97 438.61 10.45 10.64 NA NA NA 0.78 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other Assets Noncurrent 14.46 20.82 19.32 15.10 16.02 16.04 15.11 14.70 14.77 14.03 11.86 11.82 7.90 7.91 7.96 18.62 19.32 21.61 29.13 29.46 23.15 22.59 19.19 18.71 18.85 14.15 13.89 8.68 8.58 2.44 1.94 1.64 0.32 0.34 0.36 0.41 0.41 0.32 0.93 0.96 0.81 1.17 1.17 1.17 1.18 1.21 1.56 NA NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Liabilities Current 112.22 110.14 104.94 94.36 89.25 112.28 90.47 97.13 163.67 219.20 214.87 224.76 229.77 179.06 176.62 178.92 244.09 182.43 200.92 203.63 244.78 201.35 192.21 210.93 332.75 312.49 306.67 176.88 146.91 40.28 44.13 34.92 43.16 40.42 47.00 37.24 34.50 24.30 33.10 40.32 44.03 37.52 40.39 35.12 33.89 34.65 34.86 NA NA NA NA NA NA NA

Accounts Payable Current 33.16 24.06 29.74 28.57 25.99 36.99 29.59 32.60 42.67 47.54 32.53 33.83 30.88 26.93 13.49 31.56 60.18 48.56 56.77 67.50 78.63 49.23 44.72 48.79 43.77 43.99 34.72 33.04 33.51 17.26 19.20 16.99 19.05 13.96 20.98 21.27 19.26 16.64 22.67 15.71 18.62 12.64 17.99 15.75 13.65 15.34 18.38 NA NA NA NA NA NA NA

Accrued Liabilities Current 25.69 33.03 23.67 15.87 11.21 19.77 13.08 4.03 4.09 15.61 14.96 14.12 10.75 6.23 5.80 8.42 7.28 5.73 7.42 5.83 12.73 13.04 12.50 7.46 11.66 8.29 9.25 9.18 14.72 6.67 4.93 3.84 4.18 2.58 3.90 8.76 4.39 3.94 2.70 2.05 1.98 1.90 1.57 1.17 1.04 1.13 1.35 NA NA NA NA NA NA NA

Other Liabilities Current 12.88 13.39 13.39 5.66 3.88 3.29 2.27 2.27 1.77 1.12 2.71 2.85 2.85 3.65 3.65 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Long Term Debt NA NA NA 610.08 603.48 596.98 590.68 610.70 617.83 667.58 681.13 694.62 708.01 721.28 729.05 778.19 813.45 826.97 839.27 851.53 886.07 895.22 903.65 937.06 1045.46 1053.69 1061.85 1053.85 1060.52 0.98 1.01 1.04 1.07 1.11 1.14 1.17 1.35 6.39 6.51 6.78 6.91 7.04 7.16 NA NA NA 7.82 NA NA NA NA NA NA NA

Long Term Debt Noncurrent 623.86 619.34 614.95 610.08 603.48 596.98 590.68 610.70 578.48 586.27 592.94 599.55 606.07 654.43 662.20 711.34 746.61 760.13 772.42 784.69 819.22 831.66 843.53 855.38 867.22 875.45 883.61 1008.21 1014.88 0.84 0.87 0.91 0.94 0.97 1.01 1.04 1.07 5.71 5.84 6.12 6.25 6.38 6.51 6.78 6.91 7.07 7.19 NA NA NA NA NA NA NA

Other Liabilities Noncurrent 5.12 5.64 5.62 16.89 17.81 18.17 19.01 19.19 19.62 17.59 16.01 14.12 14.71 14.71 14.55 2.05 2.25 3.07 3.05 2.20 2.60 6.50 6.45 6.77 7.14 7.53 6.75 6.27 6.29 NA 0.58 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Operating Lease Liability Noncurrent 9.44 9.73 9.99 10.29 10.55 10.80 11.05 11.31 9.23 9.55 9.80 10.20 5.40 5.60 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Stockholders Equity -312.27 -277.56 -251.06 -159.31 -126.16 -47.35 -27.47 124.05 129.26 299.31 302.90 NA NA NA 334.04 NA NA NA 598.91 NA NA NA 561.12 553.92 536.65 527.29 554.05 547.14 549.27 501.52 463.41 426.91 379.30 332.32 294.47 268.76 235.82 144.87 128.58 123.61 117.92 114.71 111.12 NA NA NA 105.55 NA NA NA NA NA NA NA

Common Stock Value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 NA 0.01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.01 0.01 NA NA NA NA NA NA NA

Additional Paid In Capital Common Stock 367.13 365.57 363.96 362.53 360.76 358.36 355.24 328.91 326.94 324.79 321.16 319.06 317.01 314.64 317.02 314.59 312.32 310.13 306.82 303.38 298.34 295.28 292.78 291.21 288.91 287.76 283.30 279.87 276.22 242.03 236.18 233.49 222.15 219.71 216.79 211.38 200.73 126.36 104.08 102.70 100.91 100.47 99.52 98.93 98.37 97.81 97.08 NA NA NA NA NA NA NA

Retained Earnings Accumulated Deficit -660.71 -624.40 -596.39 -503.09 -468.19 -387.11 -364.77 -186.88 -179.74 -7.79 -1.29 8.41 25.00 19.92 32.08 39.66 29.02 16.65 306.46 317.82 305.05 291.03 277.77 272.05 257.12 248.95 278.36 274.78 280.27 266.75 233.57 199.63 163.40 118.59 83.65 60.12 37.12 20.56 26.55 22.99 19.04 16.16 13.24 11.82 10.10 9.49 9.29 NA NA NA NA NA NA NA

Accumulated Other Comprehensive Income Loss Net Of Tax -0.37 -0.40 -0.41 -0.53 -0.52 -0.52 -0.55 -0.60 -0.59 -0.55 -0.63 -0.64 -0.58 -0.66 -0.61 -0.57 -0.50 -0.51 -0.52 -0.45 -0.35 -0.22 -0.22 -0.18 -0.26 -0.30 -0.29 -0.28 -0.27 -0.31 -0.29 -0.28 -0.32 -0.05 -0.05 -0.05 -0.04 -0.05 -0.05 -0.08 -0.03 -0.02 -0.06 -0.02 -0.01 0.02 0.02 NA NA NA NA NA NA NA

Treasury Stock Value NA NA 18.27 18.26 18.25 18.12 17.44 17.42 17.39 17.18 16.39 16.34 16.30 15.84 14.48 14.42 14.36 14.29 13.89 13.81 10.29 9.86 9.25 9.19 9.15 9.15 7.35 7.28 6.99 6.99 6.08 5.96 5.96 5.96 5.96 2.73 2.03 2.03 2.03 2.03 2.03 1.93 1.59 1.35 1.35 1.21 0.87 NA NA NA NA NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1.53 1.58 1.38 1.70 2.31 3.02 1.84 1.86 1.99 3.34 1.88 1.87 2.01 4.46 2.05 1.99 1.95 3.04 2.88 2.27 2.56 2.19 1.76 1.79 1.72 2.46 3.14 2.02 2.02 4.37 1.67 1.51 1.57 1.65 3.19 2.79 2.15 0.90 0.28 0.25 0.28 0.66 NA NA NA NA NA NA NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Net Cash Provided By Used In Operating Activities -19.22 -11.31 -19.01 -1.96 -3.37 17.22 26.65 58.80 -12.38 -12.21 65.63 2.67 43.43 4.28 -5.42 87.73 39.27 54.72 15.13 27.29 77.68 -1.57 44.91 53.21 30.84 36.41 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Cash Provided By Used In Investing Activities -2.91 1.43 0.60 9.38 -3.28 -4.62 -3.75 -1.96 -2.87 -6.21 -6.23 -3.77 -8.53 -21.48 -6.56 -6.39 -8.18 13.84 -14.27 -10.56 -16.25 -10.09 -20.62 -20.68 -10.98 -6.39 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Cash Provided By Used In Financing Activities 0.03 -0.07 0.04 0.06 -0.04 -0.58 -10.95 -9.76 -54.25 -17.21 -16.55 -16.56 -16.82 -22.00 -52.94 -39.84 -17.64 -16.83 -16.22 -42.47 -13.91 -13.61 -38.55 -147.83 -14.33 -13.11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Net Cash Provided By Used In Operating Activities -19.22 -11.31 -19.01 -1.96 -3.37 17.22 26.65 58.80 -12.38 -12.21 65.63 2.67 43.43 4.28 -5.42 87.73 39.27 54.72 15.13 27.29 77.68 -1.57 44.91 53.21 30.84 36.41 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Net Income Loss -36.31 -28.02 -93.30 -34.90 -81.08 -22.34 -177.89 -7.14 -171.95 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Profit Loss -36.31 -28.02 -93.30 -34.90 -81.08 -22.34 -177.89 -7.14 -171.95 -6.50 -9.70 -16.59 5.08 -12.16 -7.59 10.64 12.36 -287.53 -11.36 12.77 14.02 13.26 5.73 14.93 8.19 -29.39 3.59 -5.47 13.54 33.20 33.96 36.26 44.82 34.95 23.55 23.01 16.59 -5.99 3.62 3.96 2.86 2.94 1.43 1.73 0.63 0.22 -1.85 -0.36 2.36 -0.39 NA NA NA NA

Depreciation Depletion And Amortization 6.29 6.21 7.61 7.79 9.29 9.59 9.48 9.63 14.38 14.34 14.92 14.51 14.09 12.79 13.56 13.41 13.82 14.80 14.48 13.28 13.58 13.78 13.78 13.59 13.65 14.32 13.36 11.96 6.21 1.91 1.56 1.41 1.30 1.31 1.21 1.62 1.58 1.57 1.58 1.53 1.54 1.55 1.53 1.40 1.38 1.42 1.32 1.29 1.15 1.22 NA NA NA NA

Increase Decrease In Accounts Receivable 25.43 -1.32 -7.73 -2.30 -28.03 -4.53 -15.86 -45.44 21.34 13.11 -54.67 21.86 -14.61 8.36 12.72 -123.56 70.01 -44.13 13.88 -17.96 13.40 39.26 -11.17 -7.75 32.46 -15.24 35.75 -45.60 -21.42 16.11 6.99 -10.93 14.81 14.51 2.09 7.82 21.66 3.34 2.23 -1.56 -0.69 -0.15 4.72 0.78 2.09 1.17 -1.40 -0.44 4.12 -7.14 NA NA NA NA

Increase Decrease In Inventories 1.25 1.63 1.49 -2.97 -5.64 5.93 -2.81 -8.73 -11.06 13.61 6.91 -16.14 2.93 5.19 4.10 0.39 -12.00 9.84 8.35 -2.30 10.20 2.79 -1.21 -6.42 2.49 12.85 -2.02 -7.28 -5.04 -0.96 1.01 -0.17 -1.43 -0.77 3.48 5.61 1.23 1.99 -0.32 2.16 3.08 0.54 -0.91 4.11 -2.61 -0.43 2.16 3.34 0.37 1.98 NA NA NA NA

Increase Decrease In Accounts Payable 9.10 -5.67 1.17 2.58 -11.00 7.41 -3.02 -10.06 -4.87 15.00 -1.30 2.95 3.96 13.43 -18.31 -28.67 11.02 -7.32 -10.73 -23.13 26.90 2.01 -6.57 2.52 -0.21 9.27 1.68 -0.47 -3.00 -1.94 1.49 -2.05 5.09 -7.02 -0.29 2.01 2.62 -6.03 6.96 -2.92 5.99 -5.35 2.24 2.10 -1.68 -3.04 1.18 2.80 -1.46 -0.52 NA NA NA NA

Share Based Compensation 1.53 1.58 1.38 1.70 2.31 3.02 1.84 1.86 1.99 3.34 1.88 1.87 2.01 4.46 2.05 1.99 1.95 3.04 2.88 2.27 2.56 2.19 1.76 1.79 1.72 2.46 3.14 2.02 2.02 4.37 1.67 1.51 1.57 1.65 3.19 2.79 2.15 0.90 0.28 0.25 0.28 0.66 0.50 0.50 0.49 0.67 0.39 0.55 0.40 0.49 NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Net Cash Provided By Used In Investing Activities -2.91 1.43 0.60 9.38 -3.28 -4.62 -3.75 -1.96 -2.87 -6.21 -6.23 -3.77 -8.53 -21.48 -6.56 -6.39 -8.18 13.84 -14.27 -10.56 -16.25 -10.09 -20.62 -20.68 -10.98 -6.39 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Payments To Acquire Property Plant And Equipment 2.41 2.77 -0.52 2.50 3.29 3.47 3.82 1.47 1.90 3.23 5.22 4.31 4.76 4.03 5.84 6.47 6.23 5.80 11.17 14.74 14.35 12.05 16.58 10.79 11.38 9.95 7.62 6.02 4.84 5.79 9.10 6.39 6.82 9.37 5.89 4.86 13.31 2.02 1.90 1.59 3.48 0.82 1.05 1.92 1.54 0.73 1.59 1.52 1.68 2.46 NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Net Cash Provided By Used In Financing Activities 0.03 -0.07 0.04 0.06 -0.04 -0.58 -10.95 -9.76 -54.25 -17.21 -16.55 -16.56 -16.82 -22.00 -52.94 -39.84 -17.64 -16.83 -16.22 -42.47 -13.91 -13.61 -38.55 -147.83 -14.33 -13.11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Payments For Repurchase Of Common Stock 0.00 0.11 0.00 0.01 0.13 0.69 0.02 0.03 0.21 0.79 0.06 0.03 0.47 1.36 0.06 0.06 0.07 0.41 0.07 3.53 0.43 0.61 0.06 0.03 0.01 1.80 0.07 0.29 0.00 0.91 NA NA NA NA 3.23 NA NA NA 0.00 0.00 0.11 0.33 0.24 0.00 0.14 0.34 0.00 0.00 0.14 0.09 NA NA NA NA

2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30

Revenues 80.89 75.08 74.19 78.36 86.51 101.53 106.01 112.37 133.92 126.48 137.92 144.37 136.11 127.34 133.84 172.79 193.72 155.05 170.91 174.39 184.31 154.96 139.12 161.72 170.94 161.56 168.89 140.11 127.06 106.43 99.28 99.35 114.82 93.39 80.62 80.00 67.33 45.83 40.17 39.02 36.56 35.29 35.69 30.69 27.73 28.88 25.51 25.89 30.04 25.40 33.76 31.27 28.72 31.43

Analgesic 2.59 3.42 3.21 3.29 3.92 5.31 4.16 3.84 3.57 3.12 1.87 2.81 2.11 1.88 2.93 0.95 2.55 1.83 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Anti Psychosis 2.58 2.62 2.63 3.35 2.10 3.71 5.70 11.68 13.32 13.03 26.35 27.86 22.70 28.03 27.91 20.62 14.04 10.89 12.43 9.34 22.80 14.99 NA NA 15.37 17.32 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Cardiovascular 13.09 10.88 12.05 9.47 9.75 14.10 13.36 16.57 16.34 19.71 21.25 21.75 23.97 21.61 31.23 22.78 25.68 21.77 24.06 18.51 10.13 11.31 NA NA 11.97 12.69 NA NA 13.08 8.30 9.44 8.46 18.33 18.94 19.34 21.33 16.92 4.52 4.52 6.99 7.27 7.10 6.63 6.05 2.95 2.51 NA NA NA NA NA NA NA NA

Central Nervous System 21.78 20.79 18.02 15.18 22.34 22.79 23.47 24.51 24.61 22.52 20.10 18.57 19.33 19.26 11.36 9.42 6.19 7.20 7.65 8.39 6.92 8.82 NA NA 10.55 10.35 NA NA 6.08 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Contract Manufacturing Revenue 5.32 3.75 4.22 2.62 2.97 1.86 4.90 3.62 6.84 5.62 6.61 5.84 6.49 5.56 2.86 7.93 7.91 4.66 4.06 5.59 6.59 3.59 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Endocrinology 5.83 7.31 4.56 6.79 8.30 7.84 7.52 6.82 9.50 3.23 NA NA NA NA -0.04 55.21 88.48 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Gastrointestinal 8.72 7.94 10.05 11.71 14.02 15.24 15.05 16.82 18.57 17.10 17.46 20.75 18.31 16.96 11.78 11.73 10.01 15.04 14.12 16.56 15.05 14.55 NA NA 18.98 18.05 NA NA 8.62 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Infectious Disease 4.99 5.07 3.54 5.44 6.52 12.52 12.18 10.61 23.04 21.93 21.52 21.75 18.08 11.89 3.69 4.16 4.62 4.48 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Migraine Headache 3.57 3.32 3.68 3.51 4.45 4.68 4.61 5.17 6.08 9.69 11.36 12.89 10.88 9.14 9.46 9.85 12.55 9.74 10.63 12.89 15.48 15.02 NA NA 7.86 7.16 NA NA 5.71 5.54 6.27 6.72 6.94 5.79 4.68 4.79 2.35 2.71 1.42 1.30 1.45 1.25 1.37 1.44 1.55 1.61 NA NA NA NA NA NA NA NA

Other Medical Indications 10.96 8.76 9.12 13.87 9.11 9.18 10.65 8.62 8.41 7.63 7.17 8.05 9.93 9.86 19.28 16.06 6.83 14.34 16.54 12.38 13.11 12.70 NA NA 11.13 11.18 NA NA 10.61 11.13 1.36 11.42 7.92 5.98 7.53 4.00 5.21 3.96 2.35 2.37 3.63 1.83 1.88 1.45 1.63 1.85 NA NA NA NA NA NA NA NA

Respiratory Allergy Cough Cold 1.47 1.20 1.67 2.31 1.87 3.11 3.02 2.55 2.27 1.43 2.83 2.97 3.08 2.71 2.96 2.55 3.39 3.58 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Urinary NA NA 1.42 0.83 1.16 1.18 1.40 1.57 1.36 1.46 1.41 1.15 1.23 0.43 1.52 2.10 1.61 1.55 2.79 0.03 2.84 3.00 NA NA 4.69 5.10 NA NA 3.38 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Revenue From Contract With Customer Excluding Assessed Tax 80.89 75.08 74.19 78.36 86.51 101.53 106.01 112.37 133.92 126.48 137.92 144.37 136.11 127.34 133.84 172.79 193.72 155.05 170.91 174.39 184.31 154.96 139.12 161.72 170.94 161.56 168.89 140.11 127.06 106.43 99.28 99.35 114.82 93.39 80.62 80.00 67.33 45.83 40.17 39.02 36.56 35.29 35.69 30.69 27.73 28.88 25.51 25.89 30.04 25.40 33.76 31.27 28.72 31.43

Analgesic 2.59 3.42 3.21 3.29 3.92 5.31 4.16 3.84 3.57 3.12 1.87 2.81 2.11 1.88 2.93 0.95 2.55 1.83 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Anti Psychosis 2.58 2.62 2.63 3.35 2.10 3.71 5.70 11.68 13.32 13.03 26.35 27.86 22.70 28.03 27.91 20.62 14.04 10.89 12.43 9.34 22.80 14.99 NA NA 15.37 17.32 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Cardiovascular 13.09 10.88 12.05 9.47 9.75 14.10 13.36 16.57 16.34 19.71 21.25 21.75 23.97 21.61 31.23 22.78 25.68 21.77 24.06 18.51 10.13 11.31 NA NA 11.97 12.69 NA NA 13.08 8.30 9.44 8.46 18.33 18.94 19.34 21.33 16.92 4.52 4.52 6.99 7.27 7.10 6.63 6.05 2.95 2.51 NA NA NA NA NA NA NA NA

Central Nervous System 21.78 20.79 18.02 15.18 22.34 22.79 23.47 24.51 24.61 22.52 20.10 18.57 19.33 19.26 11.36 9.42 6.19 7.20 7.65 8.39 6.92 8.82 NA NA 10.55 10.35 NA NA 6.08 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Contract Manufacturing Revenue 5.32 3.75 4.22 2.62 2.97 1.86 4.90 3.62 6.84 5.62 6.61 5.84 6.49 5.56 2.86 7.93 7.91 4.66 4.06 5.59 6.59 3.59 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Endocrinology 5.83 7.31 4.56 6.79 8.30 7.84 7.52 6.82 9.50 3.23 NA NA NA NA -0.04 55.21 88.48 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Gastrointestinal 8.72 7.94 10.05 11.71 14.02 15.24 15.05 16.82 18.57 17.10 17.46 20.75 18.31 16.96 11.78 11.73 10.01 15.04 14.12 16.56 15.05 14.55 NA NA 18.98 18.05 NA NA 8.62 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Infectious Disease 4.99 5.07 3.54 5.44 6.52 12.52 12.18 10.61 23.04 21.93 21.52 21.75 18.08 11.89 3.69 4.16 4.62 4.48 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Migraine Headache 3.57 3.32 3.68 3.51 4.45 4.68 4.61 5.17 6.08 9.69 11.36 12.89 10.88 9.14 9.46 9.85 12.55 9.74 10.63 12.89 15.48 15.02 NA NA 7.86 7.16 NA NA 5.71 5.54 6.27 6.72 6.94 5.79 4.68 4.79 2.35 2.71 1.42 1.30 1.45 1.25 1.37 1.44 1.55 1.61 NA NA NA NA NA NA NA NA

Other Medical Indications 10.96 8.76 9.12 13.87 9.11 9.18 10.65 8.62 8.41 7.63 7.17 8.05 9.93 9.86 19.28 16.06 6.83 14.34 16.54 12.38 13.11 12.70 NA NA 11.13 11.18 NA NA 10.61 11.13 1.36 11.42 7.92 5.98 7.53 4.00 5.21 3.96 2.35 2.37 3.63 1.83 1.88 1.45 1.63 1.85 NA NA NA NA NA NA NA NA

Respiratory Allergy Cough Cold 1.47 1.20 1.67 2.31 1.87 3.11 3.02 2.55 2.27 1.43 2.83 2.97 3.08 2.71 2.96 2.55 3.39 3.58 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Urinary NA NA 1.42 0.83 1.16 1.18 1.40 1.57 1.36 1.46 1.41 1.15 1.23 0.43 1.52 2.10 1.61 1.55 2.79 0.03 2.84 3.00 NA NA 4.69 5.10 NA NA 3.38 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Revenue From Contract With Customer Including Assessed Tax 80.89 75.08 74.19 78.36 86.51 101.53 106.01 112.37 133.92 126.48 137.92 144.37 136.11 127.34 133.84 172.79 193.72 155.05 170.91 174.39 184.31 154.96 139.12 165.72 170.94 161.56 168.89 140.11 127.06 106.43 99.28 99.35 114.82 93.39 80.62 80.00 67.33 45.83 40.17 39.02 36.56 35.29 35.69 30.69 27.73 28.88 25.51 25.89 30.04 25.40 33.76 31.27 28.72 31.43

Plots across concepts

IncomeStatement

Net Income Loss

Expenses

Income Tax Expense Benefit

Balance Sheet

Stockholders Equity

Assets

Operating Lease Right Of Use Asset

Current Assets

Other Assets Current

NonCurrent Assets

Operating Lease Right Of Use Asset

PropertyPlantAndEquipmentNet

Property Plant And Equipment Net

Liabilities

Operating Lease Liability

Current Liabilities

Operating Lease Liability Current

Noncurrent Liabilities

Other Liabilities Noncurrent

Stockholders Equity

Retained Earnings Accumulated Deficit

CashFlow

Net Income Loss

NetCashProvidedByUsedInOperatingActivities

Net Income Loss

NetCashProvidedByUsedInInvestingActivities

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInFinancingActivities

Payments For Repurchase Of Common Stock

Shares

Weighted Average Number Of Diluted Shares Outstanding

OperatingLeaseLiability

Operating Lease Liability Current

NonoperatingIncomeExpense

Nonoperating Income Expense

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

FiniteLivedIntangibleAssets

Finite Lived Intangible Assets Accumulated Amortization

InventoryNet

Inventory Work In Process Net Of Reserves

AccountsReceivable

Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept

TTM Greenblatt ROC
_
(None,)

T T M Greenblatt R O C_

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service

us-gaap:Revenues
us-gaap:ProductOrService
(None,)

Revenuesus-gaap: Product Or Service

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:OtherCommitments
(None,)

Research And Development Expense Excluding Acquired In Process Costus-gaap: Other Commitments

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)

Allocated Share Based Compensation Expenseus-gaap: Income Statement Location

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)

Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type

us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass
('lci:KremersUrbanPharmaceuticalsInc', None)

Finite Lived Intangible Assets Netus-gaap: Business Acquisition, us-gaap: Finite Lived Intangible Assets By Major Class

us-gaap:LongTermDebt
us-gaap:LongtermDebtType
(None,)

Long Term Debtus-gaap: Longterm Debt Type

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:Revenues
us-gaap:ProductOrService
(None,)

Revenuesus-gaap: Product Or Service

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service